Apollo Hospitals Enterprise liquidity ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
7.71×————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.06×1.06×1.54×1.13×1.30×
0.98×0.98×1.43×1.03×1.19×
1,8281,8282,0101,190726
4194192,4506151,012
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

APOLLOHOSP₹7,705.50

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.11L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Altman Z-Score (Other Equity as RE)————7.71
Current Ratio1.301.131.541.061.06
Quick Ratio1.191.031.430.980.98
Cash, Equiv & ST Investments725.61,189.52,010.41,827.81,827.8
Working Capital1,012.4615.22,450.0418.5418.5
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.